Concept
Discussion/Conclusion - alpha-ketoamide's effectiveness as broad-spectrum inhibitors against SARS-CoV viruses
- This study identified the key differences in the binding pocket of the main protease in the SARS-CoV viruses, the Human corona virus, and several enteroviruses.
- 11r and 11u were the two most promising broad spectrum inhibitors tested for the viruses.
- 11r was is the most promising in its effectiveness against human coronaviruses and the SARS-CoV because of the similarity between the human corona virus and the SARS-CoV virus, this could lead to promising results with further testing of this inhibitor.
- 11u is the most broad-spectrum against the viruses tested. It proved to be the most equipotent in all the viral proteases.
- 11s and 11n proved to be less promising because of their lower potencies in other viruses however it was very effective at binding to the human corona virus binding pocket.
0
1
Updated 2021-04-06
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Discussion/Conclusion - alpha-ketoamide's effectiveness as broad-spectrum inhibitors against SARS-CoV viruses
Discussion/Conclusion - alpha-ketoamide's effectiveness as broad-spectrum inhibitors against SARS-CoV viruses
Discussion/Conclusion - alpha-ketoamide's effectiveness as broad-spectrum inhibitors against SARS-CoV viruses
Discussion/Conclusion - alpha-ketoamide's effectiveness as broad-spectrum inhibitors against SARS-CoV viruses